Inhibitors of Types I and II Dehydroquinase

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|4|7|747-756

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.4, Iss.7, 2004-09, pp. : 747-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bissulfonamides as inhibitors of the dehydroquinate synthetase enzyme AroB and of the Type II dehydroquinase enzyme AroQ

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 11, 2001-11 ,pp. : 1797-1799

Informa Healthcare

Access to resources Recommend Favorite

Dual Topoisomerase I / II Inhibitors in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 339-353

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Collagen Types I, II and III in Juvenile Angiofibromas

By  

Cells Tissues Organs, Vol. 189, Iss. 6, 2008-09 ,pp. : 403-409

Karger

Access to resources Recommend Favorite

Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 960-977

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II RAF kinase inhibitors in cancer therapy

By Turajlic Samra   Ali Zohra   Yousaf Nadia   Larkin James  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 739-749

Informa Healthcare

Access to resources Recommend Favorite